Literature DB >> 24174498

Management of bilateral ureteral trauma using ureteral stents and subsequent subcutaneous ureteral bypass devices in a cat.

Elvin Kulendra1, Nicola Kulendra2, Zoe Halfacree2.   

Abstract

This report describes a cat that presented with abdominal pain and worsening azotaemia following unknown trauma. Further diagnostic investigations and surgery confirmed bilateral ureteral trauma. The cat was initially managed surgically by bilateral ureteroureterostomy over ureteral stents. The clinical signs and biochemical parameters rapidly resolved, but 2 months later the cat developed signs consistent with sterile cystitis that was unresponsive to medical management. Removal of the ureteral stents resulted in severe azotaemia as a result of stricture formation at the previous ureteral anastomosis site. The ureteral stents were initially replaced with soft stents, but subsequently cut short owing to the persistence of clinical signs of cystitis. Following shortening of the ureteral stents severe azotaemia was again observed. The resulting pelvic dilatation allowed for placement of bilateral subcutaneous ureteral bypass (SUB) systems, which resulted in alleviation of all clinical signs 12 months after SUB placement. © ISFM and AAFP 2013.

Entities:  

Mesh:

Year:  2013        PMID: 24174498     DOI: 10.1177/1098612X13509098

Source DB:  PubMed          Journal:  J Feline Med Surg        ISSN: 1098-612X            Impact factor:   2.015


  2 in total

1.  Use of a subcutaneous ureteral bypass device for treatment of bilateral proximal ureteral injury in a 9-month-old cat.

Authors:  Joseph A Sapora; Robert J Hardie; Natashia Evans
Journal:  JFMS Open Rep       Date:  2019-03-11

2.  Multicenter retrospective evaluation of transmural migration of subcutaneous ureteral bypass devices within the digestive tract in cats.

Authors:  Emilie Véran; Catherine Vachon; Julie Byron; James Howard; Allyson Berent; Chick Weisse; Romain Javard; Ashley Spencer; Sarah Gradilla; Carrie Palm; William Culp; Andréanne Cléroux; Marilyn Dunn
Journal:  J Vet Intern Med       Date:  2022-08-17       Impact factor: 3.175

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.